-
1
-
-
0035856920
-
Global and societal implications of the diabetes epidemic
-
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787
-
(2001)
Nature
, vol.414
, pp. 782-787
-
-
Zimmet, P.1
Alberti, K.G.2
Shaw, J.3
-
2
-
-
0343068395
-
Blood serum magnesium in portal cirrhosis and diabetes mellitus
-
Stutzman FL, Amatuzio DS. Blood serum magnesium in portal cirrhosis and diabetes mellitus. J Lab Clin Med 1953;41:215-219
-
(1953)
J Lab Clin Med
, vol.41
, pp. 215-219
-
-
Stutzman, F.L.1
Amatuzio, D.S.2
-
3
-
-
0018383486
-
Magnesium status in diabetes
-
Mather HM, Levin GE. Magnesium status in diabetes. Lancet 1979;1:924
-
(1979)
Lancet
, vol.1
, pp. 924
-
-
Mather, H.M.1
Levin, G.E.2
-
4
-
-
0018225204
-
Hypomagnesemia, a risk factor in diabetic retinopathy
-
McNair P, Christiansen C, Madsbad S, et al. Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 1978;27:1075-1077
-
(1978)
Diabetes
, vol.27
, pp. 1075-1077
-
-
McNair, P.1
Christiansen, C.2
Madsbad, S.3
-
6
-
-
0020086353
-
Magnesium levels of plasma, erythrocyte and urine in patients with diabetes mellitus
-
Fujii S, Takemura T, Wada M, Akai T, Okuda K. Magnesium levels of plasma, erythrocyte and urine in patients with diabetes mellitus. Horm Metab Res 1982; 14:161-162
-
(1982)
Horm Metab Res
, vol.14
, pp. 161-162
-
-
Fujii, S.1
Takemura, T.2
Wada, M.3
Akai, T.4
Okuda, K.5
-
7
-
-
0021666130
-
Magnesium and potassium in diabetes and carbohydrate metabolism review of the present status and recent results
-
Durlach J, Collery P. Magnesium and potassium in diabetes and carbohydrate metabolism. Review of the present status and recent results. Magnesium 1984;3: 315-323
-
(1984)
Magnesium
, vol.3
, pp. 315-323
-
-
Durlach, J.1
Collery, P.2
-
9
-
-
0020041933
-
Renal hypomagnesaemia in human diabetes mellitus: Its relation to glucose homeostasis
-
McNair P, Christensen MS, Christiansen C, Madsbad S, Transbol I. Renal hypomagnesaemia in human diabetes mellitus: Its relation to glucose homeostasis. Eur J Clin Invest 1982;12:81-85
-
(1982)
Eur J Clin Invest
, vol.12
, pp. 81-85
-
-
McNair, P.1
Christensen, M.S.2
Christiansen, C.3
Madsbad, S.4
Transbol, I.5
-
10
-
-
0027321697
-
Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus
-
Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993;36:767-770
-
(1993)
Diabetologia
, vol.36
, pp. 767-770
-
-
Resnick, L.M.1
Altura, B.T.2
Gupta, R.K.3
Laragh, J.H.4
Alderman, M.H.5
Altura, B.M.6
-
11
-
-
3643099977
-
The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes
-
Lima Mde L, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998;21:682-686
-
(1998)
Diabetes Care
, vol.21
, pp. 682-686
-
-
Lima Mde, L.1
Cruz, T.2
Pousada, J.C.3
Rodrigues, L.E.4
Barbosa, K.5
Cangucu, V.6
-
12
-
-
0024777685
-
Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency
-
Ryzen E, Servis KL, DeRusso P, Kershaw A, Stephen T, Rude RK. Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency. J Am Coll Nutr 1989;8:580-587
-
(1989)
J Am Coll Nutr
, vol.8
, pp. 580-587
-
-
Ryzen, E.1
Servis, K.L.2
DeRusso, P.3
Kershaw, A.4
Stephen, T.5
Rude, R.K.6
-
13
-
-
19944424137
-
Complementary therapies for diabetes: The case for chromium, magnesium, and antioxidants
-
Guerrero-Romero F, Rodriguez-Moran M. Complementary therapies for diabetes: The case for chromium, magnesium, and antioxidants. Arch Med Res 2005;36: 250-257
-
(2005)
Arch Med Res
, vol.36
, pp. 250-257
-
-
Guerrero-Romero, F.1
Rodriguez-Moran, M.2
-
14
-
-
0021239766
-
Fasting plasma magnesium concentrations and glucose disposal in diabetes
-
Yajnik CS, Smith RF, Hockaday TD, Ward NI. Fasting plasma magnesium concentrations and glucose disposal in diabetes. BMJ 1984;288:1032-1034
-
(1984)
BMJ
, vol.288
, pp. 1032-1034
-
-
Yajnik, C.S.1
Smith, R.F.2
Hockaday, T.D.3
Ward, N.I.4
-
15
-
-
2542489260
-
Role of cellular magnesium in health and human disease
-
Laires MJ, Monteiro CP, Bicho M. Role of cellular magnesium in health and human disease. Front Biosci 2004;9:262-276
-
(2004)
Front Biosci
, vol.9
, pp. 262-276
-
-
Laires, M.J.1
Monteiro, C.P.2
Bicho, M.3
-
16
-
-
0030936915
-
Hypertension, diabetes mellitus, and insulin resistance: The role of intracellular magnesium
-
Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: The role of intracellular magnesium. Am J Hypertens 1997;10:346-355
-
(1997)
Am J Hypertens
, vol.10
, pp. 346-355
-
-
Paolisso, G.1
Barbagallo, M.2
-
17
-
-
0034122983
-
Carbohydrates, dietary fiber, and incident type 2 diabetes in older women
-
Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, Folsom AR. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 2000;71: 921-930
-
(2000)
Am J Clin Nutr
, vol.71
, pp. 921-930
-
-
Meyer, K.A.1
Kushi, L.H.2
Jacobs Jr., D.R.3
Slavin, J.4
Sellers, T.A.5
Folsom, A.R.6
-
18
-
-
0036076622
-
Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the framingham offspring study
-
McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 2002;76:390-398
-
(2002)
Am J Clin Nutr
, vol.76
, pp. 390-398
-
-
McKeown, N.M.1
Meigs, J.B.2
Liu, S.3
Wilson, P.W.4
Jacques, P.F.5
-
19
-
-
0041333811
-
Dietary magnesium intake and the future risk of coronary heart disease (the honolulu heart program
-
Abbott RD, Ando F, Masaki KH, et al. Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 2003; 92:665-669
-
(2003)
Am J Cardiol
, vol.92
, pp. 665-669
-
-
Abbott, R.D.1
Ando, F.2
Masaki, K.H.3
-
20
-
-
1042268737
-
Magnesium intake and risk of type 2 diabetes in men and women
-
Lopez-Ridaura R, Willett WC, Rimm EB, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004;27:134-140
-
(2004)
Diabetes Care
, vol.27
, pp. 134-140
-
-
Lopez-Ridaura, R.1
Willett, W.C.2
Rimm, E.B.3
-
21
-
-
1042268741
-
Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women
-
Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004;27: 59-65
-
(2004)
Diabetes Care
, vol.27
, pp. 59-65
-
-
Song, Y.1
Manson, J.E.2
Buring, J.E.3
Liu, S.4
-
22
-
-
0024232088
-
Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus
-
Sjogren A, Floren CH, Nilsson A. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 1988;224:461-466
-
(1988)
Acta Med Scand
, vol.224
, pp. 461-466
-
-
Sjogren, A.1
Floren, C.H.2
Nilsson, A.3
-
23
-
-
0031884560
-
Intracellular magnesium depletion relates to increased urinary magnesium loss in type I diabetes
-
Gurlek A, Bayraktar M, Ozaltin N. Intracellular magnesium depletion relates to increased urinary magnesium loss in type I diabetes. Horm Metab Res 1998;30:99-102
-
(1998)
Horm Metab Res
, vol.30
, pp. 99-102
-
-
Gurlek, A.1
Bayraktar, M.2
Ozaltin, N.3
-
24
-
-
0022450297
-
Magnesium deficiency in IDDM related to level of glycosylated hemoglobin
-
Sjogren A, Floren CH, Nilsson A. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes 1986;35:459-463
-
(1986)
Diabetes
, vol.35
, pp. 459-463
-
-
Sjogren, A.1
Floren, C.H.2
Nilsson, A.3
-
25
-
-
0024432270
-
Subclinical hyponatremia, hyperkalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus
-
Pun KK, Ho PW. Subclinical hyponatremia, hyperkalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus. Diabetes Res Clin Pract 1989;7: 163-167
-
(1989)
Diabetes Res Clin Pract
, vol.7
, pp. 163-167
-
-
Pun, K.K.1
Ho, P.W.2
-
26
-
-
0029072419
-
Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The aric study atherosclerosis risk in communities study
-
Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995;48:927-940
-
(1995)
J Clin Epidemiol
, vol.48
, pp. 927-940
-
-
Ma, J.1
Folsom, A.R.2
Melnick, S.L.3
-
27
-
-
0026601697
-
Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-Term metabolic control
-
Schnack C, Bauer I, Pregant P, Hopmeier P, Schernthaner G. Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-Term metabolic control. Diabetologia 1992;35:77-79
-
(1992)
Diabetologia
, vol.35
, pp. 77-79
-
-
Schnack, C.1
Bauer, I.2
Pregant, P.3
Hopmeier, P.4
Schernthaner, G.5
-
28
-
-
0033030444
-
Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes
-
Djurhuus MS, Henriksen JE, Klitgaard NA, et al. Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care 1999;22:546-554
-
(1999)
Diabetes Care
, vol.22
, pp. 546-554
-
-
Djurhuus, M.S.1
Henriksen, J.E.2
Klitgaard, N.A.3
-
29
-
-
10844222546
-
Measurement of magnesium absorption and retention in type 2 diabetic patients with the use of stable isotopes
-
Walti MK, Zimmermann MB, Walczyk T, Spinas GA, Hurrell RF. Measurement of magnesium absorption and retention in type 2 diabetic patients with the use of stable isotopes. Am J Clin Nutr 2003;78:448-453
-
(2003)
Am J Clin Nutr
, vol.78
, pp. 448-453
-
-
Walti, M.K.1
Zimmermann, M.B.2
Walczyk, T.3
Spinas, G.A.4
Hurrell, R.F.5
-
30
-
-
0023125370
-
Glucose homeostasis in magnesium-deficient rats
-
Legrand C, Okitolonda W, Pottier AM, Lederer J, Henquin JC. Glucose homeostasis in magnesium-deficient rats. Metabolism 1987;36:160-164
-
(1987)
Metabolism
, vol.36
, pp. 160-164
-
-
Legrand, C.1
Okitolonda, W.2
Pottier, A.M.3
Lederer, J.4
Henquin, J.C.5
-
31
-
-
23844544155
-
Further evidence for the regulation of acetyl-CoA carboxylase activity by a glutamate-And magnesiumactivated protein phosphatase in the pancreatic beta cell: Defective regulation in the diabetic GK rat islet
-
Palanivel R, Veluthakal R, McDonald P, Kowluru A. Further evidence for the regulation of acetyl-CoA carboxylase activity by a glutamate-And magnesiumactivated protein phosphatase in the pancreatic beta cell: Defective regulation in the diabetic GK rat islet. Endocrine 2005;26:71-77
-
(2005)
Endocrine
, vol.26
, pp. 71-77
-
-
Palanivel, R.1
Veluthakal, R.2
McDonald, P.3
Kowluru, A.4
-
32
-
-
0021916198
-
Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test
-
Menzel R, Pusch H, Ratzmann GW, et al. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test. Exp Clin Endocrinol 1985;85:81-88
-
(1985)
Exp Clin Endocrinol
, vol.85
, pp. 81-88
-
-
Menzel, R.1
Pusch, H.2
Ratzmann, G.W.3
-
33
-
-
0024402335
-
Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects
-
Paolisso G, Passariello N, Pizza G, et al. Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects. Acta Endocrinol 1989;121:16-20
-
(1989)
Acta Endocrinol
, vol.121
, pp. 16-20
-
-
Paolisso, G.1
Passariello, N.2
Pizza, G.3
-
34
-
-
0024523623
-
Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects
-
Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D'Onofrio F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 1989;12:265-269
-
(1989)
Diabetes Care
, vol.12
, pp. 265-269
-
-
Paolisso, G.1
Sgambato, S.2
Pizza, G.3
Passariello, N.4
Varricchio, M.5
D'Onofrio, F.6
-
35
-
-
0026653825
-
Daily magnesium supplements improve glucose handling in elderly subjects
-
Paolisso G, Sgambato S, Gambardella A, et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 1992;55:1161-1167
-
(1992)
Am J Clin Nutr
, vol.55
, pp. 1161-1167
-
-
Paolisso, G.1
Sgambato, S.2
Gambardella, A.3
-
37
-
-
0029895208
-
Magnesium deficiency and glucose metabolism in rat adipocytes
-
Kandeel FR, Balon E, Scott S, Nadler JL. Magnesium deficiency and glucose metabolism in rat adipocytes. Metabolism 1996;45:838-843
-
(1996)
Metabolism
, vol.45
, pp. 838-843
-
-
Kandeel, F.R.1
Balon, E.2
Scott, S.3
Nadler, J.L.4
-
38
-
-
0028862204
-
Impaired tyrosinekinase activity of muscle insulin receptors from hypomagnesaemic rats
-
Suarez A, Pulido N, Casla A, Casanova B, Arrieta FJ, Rovira A. Impaired tyrosinekinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 1995;38:1262-1270
-
(1995)
Diabetologia
, vol.38
, pp. 1262-1270
-
-
Suarez, A.1
Pulido, N.2
Casla, A.3
Casanova, B.4
Arrieta, F.J.5
Rovira, A.6
-
39
-
-
0028359329
-
Dietary magnesium prevents fructose-induced insulin insensitivity in rats
-
Balon TW, Jasman A, Scott S, Meehan WP, Rude RK, Nadler JL. Dietary magnesium prevents fructose-induced insulin insensitivity in rats. Hypertension 1994;23: 1036-1039
-
(1994)
Hypertension
, vol.23
, pp. 1036-1039
-
-
Balon, T.W.1
Jasman, A.2
Scott, S.3
Meehan, W.P.4
Rude, R.K.5
Nadler, J.L.6
-
40
-
-
0028874537
-
Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM
-
Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol 1995;269:E745-E752
-
(1995)
Am J Physiol
, vol.269
-
-
Balon, T.W.1
Gu, J.L.2
Tokuyama, Y.3
Jasman, A.P.4
Nadler, J.L.5
-
41
-
-
4243066297
-
Intracellular magnesium and insulin resistance
-
Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res 2004;17:126-136
-
(2004)
Magnes Res
, vol.17
, pp. 126-136
-
-
Takaya, J.1
Higashino, H.2
Kobayashi, Y.3
-
42
-
-
0026095250
-
Cellular ions in hypertension, diabetes, and obesity a nuclear magnetic resonance spectroscopic study
-
Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH. Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension 1991;17:951-957
-
(1991)
Hypertension
, vol.17
, pp. 951-957
-
-
Resnick, L.M.1
Gupta, R.K.2
Bhargava, K.K.3
Gruenspan, H.4
Alderman, M.H.5
Laragh, J.H.6
-
43
-
-
0037326196
-
Peroxisome proliferator-Activated receptor-gamma coactivator 1 alpha (pgc-1 alpha): Transcriptional coactivator and metabolic regulator
-
Puigserver P, Spiegelman BM. Peroxisome proliferator-Activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): Transcriptional coactivator and metabolic regulator. Endocr Rev 2003;24:78-90
-
(2003)
Endocr Rev
, vol.24
, pp. 78-90
-
-
Puigserver, P.1
Spiegelman, B.M.2
-
44
-
-
0037398675
-
Pioglitazone increases serum magnesium levels in glucose-intolerant subjects a randomized, controlled trial
-
Guerrero-Romero F, Rodriguez-Moran M. Pioglitazone increases serum magnesium levels in glucose-intolerant subjects. A randomized, controlled trial. Exp Clin Endocrinol Diabetes 2003;111:91-96
-
(2003)
Exp Clin Endocrinol Diabetes
, vol.111
, pp. 91-96
-
-
Guerrero-Romero, F.1
Rodriguez-Moran, M.2
-
45
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
46
-
-
0032896330
-
Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas
-
Emoto M, Nishizawa Y, Maekawa K, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999;22:818-822
-
(1999)
Diabetes Care
, vol.22
, pp. 818-822
-
-
Emoto, M.1
Nishizawa, Y.2
Maekawa, K.3
-
47
-
-
0034456568
-
Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans
-
Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 2402-2410
-
-
Katz, A.1
Nambi, S.S.2
Mather, K.3
-
48
-
-
12144290252
-
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose
-
Yokoyama H, Emoto M, Fujiwara S, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab 2004;89:1481-1484
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 1481-1484
-
-
Yokoyama, H.1
Emoto, M.2
Fujiwara, S.3
-
49
-
-
18144423955
-
Magnesium deficiency is associated with insulin resistance in obese children
-
Huerta MG, Roemmich JN, Kington ML, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005;28:1175-1181
-
(2005)
Diabetes Care
, vol.28
, pp. 1175-1181
-
-
Huerta, M.G.1
Roemmich, J.N.2
Kington, M.L.3
-
50
-
-
0028934616
-
Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: Evidence for insulin resistance
-
Alzaid AA, Dinneen SF, Moyer TP, Rizza RA. Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: Evidence for insulin resistance. J Clin Endocrinol Metab 1995;80:1376-1381
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 1376-1381
-
-
Alzaid, A.A.1
Dinneen, S.F.2
Moyer, T.P.3
Rizza, R.A.4
-
51
-
-
0032869614
-
Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic black americans
-
Humphries S, Kushner H, Falkner B. Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans. Am J Hypertens 1999;12:747-756
-
(1999)
Am J Hypertens
, vol.12
, pp. 747-756
-
-
Humphries, S.1
Kushner, H.2
Falkner, B.3
-
52
-
-
0027278837
-
Magnesium deficiency produces insulin resistance and increased thromboxane synthesis
-
Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993;21:1024-1029
-
(1993)
Hypertension
, vol.21
, pp. 1024-1029
-
-
Nadler, J.L.1
Buchanan, T.2
Natarajan, R.3
Antonipillai, I.4
Bergman, R.5
Rude, R.6
-
53
-
-
0030702902
-
Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects
-
Rosolova H, Mayer O Jr, Reaven G. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. J Clin Endocrinol Metab 1997;82:3783-3785
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 3783-3785
-
-
Rosolova, H.1
Mayer Jr., O.2
Reaven, G.3
-
54
-
-
0034064791
-
Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations
-
Rosolova H, Mayer O Jr, Reaven GM. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism 2000;49:418-420
-
(2000)
Metabolism
, vol.49
, pp. 418-420
-
-
Rosolova, H.1
Mayer Jr., O.2
Reaven, G.M.3
-
55
-
-
0026635837
-
Diet and risk of clinical diabetes in women
-
Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in women. Am J Clin Nutr 1992;55:1018-1023
-
(1992)
Am J Clin Nutr
, vol.55
, pp. 1018-1023
-
-
Colditz, G.A.1
Manson, J.E.2
Stampfer, M.J.3
Rosner, B.4
Willett, W.C.5
Speizer, F.E.6
-
56
-
-
0036721480
-
Whole-grain intake and the risk of type 2 diabetes: A prospective study in men
-
Fung TT, Hu FB, Pereira MA, et al. Whole-grain intake and the risk of type 2 diabetes: A prospective study in men. Am J Clin Nutr 2002;76:535-540
-
(2002)
Am J Clin Nutr
, vol.76
, pp. 535-540
-
-
Fung, T.T.1
Hu, F.B.2
Pereira, M.A.3
-
57
-
-
0037184499
-
Nut and peanut butter consumption and risk of type 2 diabetes in women
-
Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 2002;288:2554-2560
-
(2002)
JAMA
, vol.288
, pp. 2554-2560
-
-
Jiang, R.1
Manson, J.E.2
Stampfer, M.J.3
Liu, S.4
Willett, W.C.5
Hu, F.B.6
-
58
-
-
0033547207
-
Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The atherosclerosis risk in communities study
-
Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study. Arch Intern Med 1999;159:2151-2159
-
(1999)
Arch Intern Med
, vol.159
, pp. 2151-2159
-
-
Kao, W.H.1
Folsom, A.R.2
Nieto, F.J.3
Mo, J.P.4
Watson, R.L.5
Brancati, F.L.6
-
59
-
-
0028227194
-
Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients
-
Paolisso G, Scheen A, Cozzolino D, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994;78:1510-1514
-
(1994)
J Clin Endocrinol Metab
, vol.78
, pp. 1510-1514
-
-
Paolisso, G.1
Scheen, A.2
Cozzolino, D.3
-
60
-
-
0041666626
-
Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: A randomized double-blind controlled trial
-
Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: A randomized double-blind controlled trial. Diabetes Care 2003;26:1147-1152
-
(2003)
Diabetes Care
, vol.26
, pp. 1147-1152
-
-
Rodriguez-Moran, M.1
Guerrero-Romero, F.2
-
61
-
-
16644365360
-
Clinical Efficacy of magnesium supplementation in patients with type 2 diabetes
-
Yokota K, Kato M, Lister F, et al. Clinical Efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 2004;23:506S-509S
-
(2004)
J Am Coll Nutr
, vol.23
-
-
Yokota, K.1
Kato, M.2
Lister, F.3
-
62
-
-
0028297080
-
Effect of magnesium treatment on glycemic control and metabolic parameters in niddm patients
-
Gullestad L, Jacobsen T, Dolva LO. Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients. Diabetes Care 1994;17:460-461
-
(1994)
Diabetes Care
, vol.17
, pp. 460-461
-
-
Gullestad, L.1
Jacobsen, T.2
Dolva, L.O.3
-
63
-
-
0028928701
-
Hypomagnesemia in type II diabetes: Effect of a 3-month replacement therapy
-
Eibl NL, Kopp HP, Nowak HR, Schnack CJ, Hopmeier PG, Schernthaner G. Hypomagnesemia in type II diabetes: Effect of a 3-month replacement therapy. Diabetes Care 1995;18:188-192
-
(1995)
Diabetes Care
, vol.18
, pp. 188-192
-
-
Eibl, N.L.1
Kopp, H.P.2
Nowak, H.R.3
Schnack, C.J.4
Hopmeier, P.G.5
Schernthaner, G.6
-
64
-
-
0031864270
-
Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients
-
de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients. Diabetes Med 1998;15:503-507
-
(1998)
Diabetes Med
, vol.15
, pp. 503-507
-
-
De Valk, H.W.1
Verkaaik, R.2
Van Rijn, H.J.3
Geerdink, R.A.4
Struyvenberg, A.5
-
65
-
-
3142708531
-
Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance A double-blind placebo-controlled randomized trial
-
Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004;30:253-258
-
(2004)
Diabetes Metab
, vol.30
, pp. 253-258
-
-
Guerrero-Romero, F.1
Tamez-Perez, H.E.2
Gonzalez-Gonzalez, G.3
-
66
-
-
1042280180
-
A new dietary approach to reduce the risk of type 2 diabetes
-
Nadler JL. A new dietary approach to reduce the risk of type 2 diabetes? Diabetes Care 2004;27:270-271.
-
(2004)
Diabetes Care
, vol.27
, pp. 270-271
-
-
Nadler, J.L.1
|